Diazacarbazole derivatives as tau-PET-ligands
US-10004817-B2 · Jun 26, 2018 · US
Diazacarbazole derivatives as tau-PET-ligands
US11058781B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11058781-B2 |
| Application number | US-201815980080-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 15, 2018 |
| Priority date | Oct 8, 2013 |
| Publication date | Jul 13, 2021 |
| Grant date | Jul 13, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to compounds that may be used for binding and imaging tau aggregates and related beta-sheet aggregates including, besides others, beta-amyloid aggregates or alpha-synuclein aggregates.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound that is 2-(6-fluoro-pyridin-3-yl)-dipyrido[2,3-b;3′,4′-d]pyrrole-9-carboxylic acid tert-butyl ester.
Assignees
Inventors
Classifications
- C07D471/04Primary
Ortho-condensed systems · CPC title
Ortho-condensed systems · CPC title
- A61K51/0455Primary
having six-membered rings with one nitrogen as the only ring hetero atom · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
Alzheimer · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11058781B2 cover?
- The present invention relates to compounds that may be used for binding and imaging tau aggregates and related beta-sheet aggregates including, besides others, beta-amyloid aggregates or alpha-synuclein aggregates.
- Who is the assignee on this patent?
- Hoffmann La Roche
- What technology area does this patent fall under?
- Primary CPC classification C07D471/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).